Towa CMO/CDMO

We expanded our commitment to health through a new business line: Towa CMO/CDMO. Backed by decades of pharmaceutical experience and robust industrial capabilities, we now offer our production and/or R&D potential to other generic and/or innovative companies in the pharmaceutical sector to develop and manufacture their medicines.

Our production plant in Barcelona, covering more than 35,000 m², is one of the largest in Europe. Equipped with cutting-edge technology and compliant with the highest quality and international regulatory standards, it ensures efficiency, flexibility, and fast time-to-market. Our R&D center and pilot plant have also acquired a fundamental role, becoming the center of excellence for our company’s parent company, Towa Pharmaceutical. With an annual production capacity exceeding 34.5 billion units, our output continues to grow steadily year after year.

Explore our production plant through an immersive virtual tour.

We work closely with our partners to turn projects into reliable treatments, combining scientific rigor with customer-centric flexibility.